Loading...

Mesenchymal Stem (Stromal) Cells for Treatment of ARDS: A Phase 1 Clinical Trial

BACKGROUND: There is no effective pharmacotherapy for the acute respiratory distress syndrome (ARDS), and mortality remains high. Preclinical studies support the efficacy of mesenchymal stem (stromal) cells (MSCs) in the treatment of lung injury. The aim of this phase one clinical trial was to test...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Lancet Respir Med
Main Authors: Wilson, Jennifer G., Liu, Kathleen D., Zhuo, Hanjing, Caballero, Lizette, McMillan, Melanie, Fang, Xiaohui, Cosgrove, Katherine, Vojnik, Rosemary, Calfee, Carolyn S., Lee, Jae-Woo, Rogers, Angela J., Levitt, Joseph, Wiener-Kronish, Jeanine, Bajwa, Ednan K., Leavitt, Andrew, McKenna, David, Thompson, B. Taylor, Matthay, Michael A.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297579/
https://ncbi.nlm.nih.gov/pubmed/25529339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(14)70291-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!